Replies to post #2564 on Galectin Therapeutics Inc. (GALT)

[biotech2010]

Several months to compile blood data on 30 patients? They were able to 'compile' the blood data for the Phase 1 trial in real time so I doubt that this is a real estimate, particularly since the blood data could have possibly cleaned up some of the stench of the rest of the trial.

I don't understand your comments about release of the CX trial data, it's December, 2017, period. If you have something in writing from the company that says something else post it just as I posted the emails back from Traber.